# FDA Inspection 1298596 - GlaxoSmithKline LLC - February 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/558e3151-6c61-4840-b704-23ee0ddfae8c
Source feed: FDA_Inspections

> FDA Inspection 1298596 for GlaxoSmithKline LLC on February 20, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1298596
- Company Name: GlaxoSmithKline LLC
- Inspection Date: 2026-02-20
- Product Type: Human Drugs
- Office Name: Atlanta District Office

## Related Documents

- [FDA Inspection 1298596 - 2026-02-20](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/1f15243a-fedd-4944-b624-120194c0b3fc)
- [FDA Inspection 1229588 - 2024-04-19](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/d81fd5bf-3526-4a54-88e1-61ea98c30e1d)
- [FDA Inspection 1043270 - 2018-01-26](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/966a55ce-96ca-4697-a725-b1bc1215536c)
- [FDA Inspection 987392 - 2016-04-21](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/cc81defe-1000-49a7-8e5a-3c8096621bd1)
- [FDA Inspection 940149 - 2015-08-21](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/9e062142-d7f0-4857-982a-b4af557a7c13)

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7